HEPATIC INSUFFICIENCY
Clinical trials for HEPATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for HEPATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study to test drug safety in vulnerable groups
Knowledge-focused Not yet recruitingThis study looks at how the drug anaprazole sodium moves through the body and how safe it is in adults with liver or kidney problems, as well as in older adults. About 60 participants will be enrolled. The goal is to gather information, not to treat any condition.
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE4 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 10:27 UTC
-
New drug safety check for liver patients
Knowledge-focused Not yet recruitingThis early-stage study looks at how a new drug, INCB123667, is processed by the body in people with moderate or severe liver disease. Researchers will monitor safety and drug levels in 16 adults aged 18 to 80. The goal is to gather important information, not to treat the liver co…
Matched conditions: HEPATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC